Replying to:
An article entitled by Clémence Roux, Gabriel Revon-Riv, Laetitia Padovani from the children hospital of AP-HM and Nicolas André from AP-HM and MGHI entitled : Metronomic Maintenance With Weekly Vinblastine After Induction With Bevacizumab-Irinotecan in Children With Low-grade Glioma Prevents Early Relapse: has just been published in the Journal of Pediatric Hematology and Oncology.
Pediatric low-grade glioma (pLGG) represents the most common brain tumor in childhood and previous studies (...)